The Fellow on Call: The Heme/Onc Podcast cover image

Episode 138: Follicular Lymphoma Series, Pt 3 - Relapsed/Refractory Management (non-cellular therapy options)

The Fellow on Call: The Heme/Onc Podcast

00:00

Relapse Management: Options Beyond Cellular Therapy

Approach for low-burden or frail relapses, second-line choices (lenalidomide+rituximab vs chemo), INMIND triplet results, obinutuzumab+lenalidomide maintenance concerns, and oral tazemetostat clinical role.

Transcript
Play full episode

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app